We are assessing the safety of a new treatment called ES2B-C001, with or without Montanide, for patients with HER2 expressing metastatic breast cancer. This trial aims to understand how safe this new approach is for patients.
Health conditions and diseases that the clinical trial is designed to study and treat.
HER2 positive breast cancer is a type of breast cancer that tests positive for the human epidermal growth factor receptor 2 (HER2), which promotes the growth of cancer cells. This subtype often requires specific treatments aimed at targeting the HER2 protein.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.